Mitochondrial H2O2 signaling is controlled by the concerted action of peroxiredoxin III and sulfiredoxin: Linking mitochondrial function to circadian rhythm

Free Radical Biology and Medicine

Volumn 100, Issue , 2016, Pages 73-80

  Rhee, Sue Goo ^a   Kil, In Sup ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Circadian rhythm; Cysteine sulfinic acid; Hydrogen peroxide; Mitochondria; Peroxidase; Peroxiredoxin; Sulfiredoxin

Indexed keywords

CYSTEINE; DISULFIDE; ENDOPEPTIDASE LA; HEAT SHOCK PROTEIN 90; HYDROGEN PEROXIDE; PEROXIREDOXIN 3; SULFINIC ACID DERIVATIVE; SULFIREDOXIN; UNCLASSIFIED DRUG; OXIDOREDUCTASE;

ADRENAL GLAND; BROWN ADIPOSE TISSUE; CELL FUNCTION; CHOLESTEROL METABOLISM; CIRCADIAN RHYTHM; DEGRADATION; ENERGY METABOLISM; ENZYME INACTIVATION; HEART; MITOCHONDRION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEROIDOGENESIS; ANIMAL; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; CIRCADIAN RHYTHM; HUMANS; HYDROGEN PEROXIDE; MICE; MITOCHONDRIA; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; PEROXIREDOXIN III; SIGNAL TRANSDUCTION;

EID: 84994316377     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.10.011     Document Type: Review

References (66)

1. [1] Shadel, G.S., Horvath, T.L., Mitochondrial ROS signaling in organismal homeostasis. Cell 163 (2015), 560–569.
2. [2] Tait, S.W., Green, D.R., Mitochondria and cell signalling. J. Cell Sci. 125 (2012), 807–815.
3. [3] Figueira, T.R., Barros, M.H., Camargo, A.A., Castilho, R.F., Ferreira, J.C., Kowaltowski, A.J., Sluse, F.E., Souza-Pinto, N.C., Vercesi, A.E., Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. Antioxid. Redox Signal. 18 (2013), 2029–2074.
4. [4] Chandel, N.S., Evolution of mitochondria as signaling organelles. Cell Metab. 22 (2015), 204–206.
5. [5] Sena, L.A., Chandel, N.S., Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48 (2012), 158–167.
6. [6] Collins, Y., Chouchani, E.T., James, A.M., Menger, K.E., Cocheme, H.M., Murphy, M.P., Mitochondrial redox signalling at a glance. J. Cell Sci. 125 (2012), 801–806.
7. [7] Sabharwal, S.S., Schumacker, P.T., Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel?. Nat. Rev. Cancer 14 (2014), 709–721.
8. [8] Balaban, R.S., Nemoto, S., Finkel, T., Mitochondria, oxidants, and aging. Cell 120 (2005), 483–495.
9. [9] Hamanaka, R.B., Chandel, N.S., Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem. Sci. 35 (2010), 505–513.
10. [10] West, A.P., Shadel, G.S., Ghosh, S., Mitochondria in innate immune responses. Nat. Rev. Immunol. 11 (2011), 389–402.
11. [11] Hamanaka, R.B., Glasauer, A., Hoover, P., Yang, S., Blatt, H., Mullen, A.R., Getsios, S., Gottardi, C.J., DeBerardinis, R.J., Lavker, R.M., Chandel, N.S., Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle development. Sci. Signal., 6, 2013 ra8.
12. [12] Kil, I.S., Lee, S.K., Ryu, K.W., Woo, H.A., Hu, M.C., Bae, S.H., Rhee, S.G., Feedback control of adrenal steroidogenesis via H2O2-dependent, reversible inactivation of peroxiredoxin III in mitochondria. Mol. Cell 46 (2012), 584–594.
13. [13] Murphy, M.P., How mitochondria produce reactive oxygen species. Biochem. J. 417 (2009), 1–13.
14. [14] Brand, M.D., The sites and topology of mitochondrial superoxide production. Exp. Gerontol. 45 (2010), 466–472.
15. [15] Quinlan, C.L., Perevoshchikova, I.V., Hey-Mogensen, M., Orr, A.L., Brand, M.D., Sites of reactive oxygen species generation by mitochondria oxidizing different substrates. Redox Biol. 1 (2013), 304–312.
16. [16] Hurd, T.R., Requejo, R., Filipovska, A., Brown, S., Prime, T.A., Robinson, A.J., Fearnley, I.M., Murphy, M.P., Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit: potential role of CYS residues in decreasing oxidative damage. J. Biol. Chem. 283 (2008), 24801–24815.
17. [17] Mailloux, R.J., Willmore, W.G., S-glutathionylation reactions in mitochondrial function and disease. Front. Cell Dev. Biol., 2, 2014, 68.
18. [18] Chouchani, E.T., Methner, C., Nadtochiy, S.M., Logan, A., Pell, V.R., Ding, S., James, A.M., Cocheme, H.M., Reinhold, J., Lilley, K.S., Partridge, L., Fearnley, I.M., Robinson, A.J., Hartley, R.C., Smith, R.A., Krieg, T., Brookes, P.S., Murphy, M.P., Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat. Med. 19 (2013), 753–759.
19. [19] Acin-Perez, R., Carrascoso, I., Baixauli, F., Roche-Molina, M., Latorre-Pellicer, A., Fernandez-Silva, P., Mittelbrunn, M., Sanchez-Madrid, F., Perez-Martos, A., Lowell, C.A., Manfredi, G., Enriquez, J.A., ROS-triggered phosphorylation of complex II by Fgr kinase regulates cellular adaptation to fuel use. Cell Metab. 19 (2014), 1020–1033.
20. [20] Doulias, P.T., Tenopoulou, M., Greene, J.L., Raju, K., Ischiropoulos, H., Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation. Sci. Signal., 6, 2013 rs1.
21. [21] Salvi, M., Battaglia, V., Brunati, A.M., La Rocca, N., Tibaldi, E., Pietrangeli, P., Marcocci, L., Mondovi, B., Rossi, C.A., Toninello, A., Catalase takes part in rat liver mitochondria oxidative stress defense. J. Biol. Chem. 282 (2007), 24407–24415.
22. [22] Radi, R., Turrens, J.F., Chang, L.Y., Bush, K.M., Crapo, J.D., Freeman, B.A., Detection of catalase in rat heart mitochondria. J. Biol. Chem. 266 (1991), 22028–22034.
23. [23] Rindler, P.M., Plafker, S.M., Szweda, L.I., Kinter, M., High dietary fat selectively increases catalase expression within cardiac mitochondria. J. Biol. Chem. 288 (2013), 1979–1990.
24. [24] Cao, C., Leng, Y., Kufe, D., Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J. Biol. Chem. 278 (2003), 29667–29675.
25. [25] Cabigas, E.B., Liu, J., Boopathy, A.V., Che, P.L., Crawford, B.H., Baroi, G., Bhutani, S., Shen, M., Wagner, M.B., Davis, M.E., Dysregulation of catalase activity in newborn myocytes during hypoxia is mediated by c-Abl tyrosine kinase. J. Cardiovasc. Pharmacol. Ther. 20 (2015), 93–103.
26. [26] Cao, C., Leng, Y., Huang, W., Liu, X., Kufe, D., Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases. J. Biol. Chem. 278 (2003), 39609–39614.
27. [27] Rafikov, R., Kumar, S., Aggarwal, S., Hou, Y., Kangath, A., Pardo, D., Fineman, J.R., Black, S.M., Endothelin-1 stimulates catalase activity through the PKCdelta-mediated phosphorylation of serine 167. Free Radic. Biol. Med. 67 (2014), 255–264.
28. [28] Rhee, S.G., Chae, H.Z., Kim, K., Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38 (2005), 1543–1552.
29. [29] Rhee, S.G., Overview on peroxiredoxin. Mol. Cells 39 (2016), 1–5.
30. [30] Rhee, S.G., Woo, H.A., Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger H(2)O(2), and protein chaperones. Antioxid. Redox Signal. 15 (2011), 781–794.
31. [31] Fisher, A.B., Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A(2) activities. Antioxid. Redox Signal. 15 (2011), 831–844.
32. [32] Knoops, B., Goemaere, J., Van der Eecken, V., Declercq, J.P., Peroxiredoxin 5: structure, mechanism, and function of the mammalian atypical 2-Cys peroxiredoxin. Antioxid. Redox Signal. 15 (2011), 817–829.
33. [33] Nakamura, T., Kado, Y., Yamaguchi, T., Matsumura, H., Ishikawa, K., Inoue, T., Crystal structure of peroxiredoxin from Aeropyrum pernix K1 complexed with its substrate, hydrogen peroxide. J. Biochem. 147 (2010), 109–115.
34. [34] Perkins, A., Nelson, K.J., Parsonage, D., Poole, L.B., Karplus, P.A., Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling. Trends Biochem. Sci. 40 (2015), 435–445.
35. [35] Manta, B., Hugo, M., Ortiz, C., Ferrer-Sueta, G., Trujillo, M., Denicola, A., The peroxidase and peroxynitrite reductase activity of human erythrocyte peroxiredoxin 2. Arch. Biochem. Biophys. 484 (2009), 146–154.
36. [36] Cox, A.G., Peskin, A.V., Paton, L.N., Winterbourn, C.C., Hampton, M.B., Redox potential and peroxide reactivity of human peroxiredoxin 3. Biochemistry 48 (2009), 6495–6501.
37. [37] Cox, A.G., Winterbourn, C.C., Hampton, M.B., Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem. J. 425 (2010), 313–325.
38. [38] Woo, H.A., Chae, H.Z., Hwang, S.C., Yang, K.S., Kang, S.W., Kim, K., Rhee, S.G., Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300 (2003), 653–656.
39. [39] Wood, Z.A., Poole, L.B., Karplus, P.A., Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300 (2003), 650–653.
40. [40] Yang, K.S., Kang, S.W., Woo, H.A., Hwang, S.C., Chae, H.Z., Kim, K., Rhee, S.G., Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J. Biol. Chem. 277 (2002), 38029–38036.
41. [41] Rabilloud, T., Heller, M., Gasnier, F., Luche, S., Rey, C., Aebersold, R., Benahmed, M., Louisot, P., Lunardi, J., Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 277 (2002), 19396–19401.
42. [42] Jang, H.H., Lee, K.O., Chi, Y.H., Jung, B.G., Park, S.K., Park, J.H., Lee, J.R., Lee, S.S., Moon, J.C., Yun, J.W., Choi, Y.O., Kim, W.Y., Kang, J.S., Cheong, G.W., Yun, D.J., Rhee, S.G., Cho, M.J., Lee, S.Y., Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function. Cell 117 (2004), 625–635.
43. [43] Moon, J.C., Hah, Y.S., Kim, W.Y., Jung, B.G., Jang, H.H., Lee, J.R., Kim, S.Y., Lee, Y.M., Jeon, M.G., Kim, C.W., Cho, M.J., Lee, S.Y., Oxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death. J. Biol. Chem. 280 (2005), 28775–28784.
44. [44] Biteau, B., Labarre, J., Toledano, M.B., ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425 (2003), 980–984.
45. [45] Jonsson, T.J., Murray, M.S., Johnson, L.C., Lowther, W.T., Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate. J. Biol. Chem. 283 (2008), 23846–23851.
46. [46] Chang, T.S., Jeong, W., Woo, H.A., Lee, S.M., Park, S., Rhee, S.G., Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J. Biol. Chem. 279 (2004), 50994–51001.
47. [47] Boileau, C., Eme, L., Brochier-Armanet, C., Janicki, A., Zhang, C.C., Latifi, A., A eukaryotic-like sulfiredoxin involved in oxidative stress responses and in the reduction of the sulfinic form of 2-Cys peroxiredoxin in the cyanobacterium Anabaena PCC 7120. New Phytol. 191 (2011), 1108–1118.
48. [48] Peskin, A.V., Dickerhof, N., Poynton, R.A., Paton, L.N., Pace, P.E., Hampton, M.B., Winterbourn, C.C., Hyperoxidation of peroxiredoxins 2 and 3: rate constants for the reactions of the sulfenic acid of the peroxidatic cysteine. J. Biol. Chem. 288 (2013), 14170–14177.
49. [49] Poynton, R.A., Peskin, A.V., Haynes, A.C., Lowther, W.T., Hampton, M.B., Winterbourn, C.C., Kinetic analysis of structural influences on the susceptibility of peroxiredoxins 2 and 3 to hyperoxidation. Biochem. J. 473 (2016), 411–421.
50. [50] Woo, H.A., Kang, S.W., Kim, H.K., Yang, K.S., Chae, H.Z., Rhee, S.G., Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulfinic acid. Immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence. J. Biol. Chem. 278 (2003), 47361–47364.
51. [51] Bae, S.H., Sung, S.H., Cho, E.J., Lee, S.K., Lee, H.E., Woo, H.A., Yu, D.Y., Kil, I.S., Rhee, S.G., Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver. Hepatology 53 (2011), 945–953.
52. [52] Kil, I.S., Ryu, K.W., Lee, S.Y., Kim, Y.Y., Chu, S.Y., Kim, J.H., Park, S., Rhee, S.G., Circadian oscillation of sulfiredoxin in the mitochondria. Mol. Cell 59 (2015), 1–13.
53. [53] Hanukoglu, I., Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab. Rev. 38 (2006), 171–196.
54. [54] Matsuzawa, A., Ichijo, H., Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim. Biophys. Acta 1780 (2008), 1325–1336.
55. [55] Nadeau, P.J., Charette, S.J., Toledano, M.B., Landry, J., Disulfide Bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H(2)O(2)-induced c-Jun NH(2)-terminal kinase activation and apoptosis. Mol. Biol. Cell 18 (2007), 3903–3913.
56. [56] A. Barajas, A. Basye, M.G. Angelos, C-A. Chen, Modulation of p38 kinase by DUSP4 is important in regulating cardiovascular function under oxidative stress. Free Radic. Biol. Med., 2015.
57. [57] Jefcoate, C.R., Lee, J., Cherradi, N., Takemori, H., Duan, H., cAMP stimulation of StAR expression and cholesterol metabolism is modulated by co-expression of labile suppressors of transcription and mRNA turnover. Mol. Cell. Endocrinol. 336 (2011), 53–62.
58. [58] Oster, H., Damerow, S., Kiessling, S., Jakubcakova, V., Abraham, D., Tian, J., Hoffmann, M.W., Eichele, G., The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab. 4 (2006), 163–173.
59. [59] Asher, G., Schibler, U., Crosstalk between components of circadian and metabolic cycles in mammals. Cell Metab. 13 (2011), 125–137.
60. [60] Peek, C.B., Affinati, A.H., Ramsey, K.M., Kuo, H.Y., Yu, W., Sena, L.A., Ilkayeva, O., Marcheva, B., Kobayashi, Y., Omura, C., Levine, D.C., Bacsik, D.J., Gius, D., Newgard, C.B., Goetzman, E., Chandel, N.S., Denu, J.M., Mrksich, M., Bass, J., Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science, 342, 2013, 1243417.
61. [61] Gerhart-Hines, Z., Feng, D., Emmett, M.J., Everett, L.J., Loro, E., Briggs, E.R., Bugge, A., Hou, C., Ferrara, C., Seale, P., Pryma, D.A., Khurana, T.S., Lazar, M.A., The nuclear receptor Rev-erbalpha controls circadian thermogenic plasticity. Nature 503 (2013), 410–413.
62. [62] Noh, Y.H., Baek, J.Y., Jeong, W., Rhee, S.G., Chang, T.S., Sulfiredoxin translocation into mitochondria plays a crucial role in reducing hyperoxidized peroxiredoxin III. J. Biol. Chem. 284 (2009), 8470–8477.
63. [63] Chacinska, A., Koehler, C.M., Milenkovic, D., Lithgow, T., Pfanner, N., Importing mitochondrial proteins: machineries and mechanisms. Cell 138 (2009), 628–644.
64. [64] Street, T.O., Lavery, L.A., Agard, D.A., Substrate binding drives large-scale conformational changes in the Hsp90 molecular chaperone. Mol. Cell 42 (2011), 96–105.
65. [65] Bota, D.A., Davies, K.J., Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat. Cell Biol. 4 (2002), 674–680.
66. [66] Voos, W., Chaperone-protease networks in mitochondrial protein homeostasis. Biochim. Biophys. Acta 1833 (2013), 388–399.